Although patients with lower expression of SSBP2 potentially have poorer OS, this did not reach statistical significance (median OS, 29.8 months vs. 42.3 months for low and high expressions respectively, HR 1.886, 95% CI 0.812–4.378, p = 0.140) (Fig. 4 ).
← all excerpts
A set of molecular markers predicts chemosensitivity to Mitomycin-C following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastasis.
1
0.1400
0.1400